[Ref], As with all therapeutic proteins, the potential for immunogenicity exits. Abasaglar è un medicinale “biosimilare”. Esso contiene insulina glargine, che è un'insulina ad azione prolungata. Toujeo is not for use to treat diabetic ketoacidosis Estrarre il cappuccio esterno dell’ago. Sono perfettamente funzionali se usati con le penne per iniezione elencate nel sito web e … Tenere l’ago diritto e avvitarlo sulla penna fino a quando è ben saldo. 0 Passaggio tra insulina glargine 100 unità/ml e Toujeo The presence of insulin antibodies may increase or decrease the efficacy of insulin and may require dose adjustment. endstream endobj 71 0 obj <> endobj 72 0 obj <> endobj 73 0 obj <>stream 5. The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. B . TOUJEO contains 300 units/mL insulin glargine Per ogni iniezione dovrà essere sempre utilizzato un nuovo ago sterile. Available for Android and iOS devices. Warnings and Precautions. It delivers doses in 2-unit increments and can deliver up to 160 units in a single injection. The concentration of insulin glargine in Toujeo is 300 units per mL. Toujeo è un'insulina basale da somministrare una volta al giorno a qualsiasi ora della giornata, preferibilmente alla stessa ora ogni giorno. U.S. Food and Drug Administration "FDA Drug Safety Communication: Update to ongoing safety review of Lantus (insulin glargine) and possible risk of cancer. Available from: URL: http://www.fda.gov/Drugs/DrugSafety/ucm239376.htm." Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them: Adverse reactions associated with insulin glargine (the active ingredient contained in Toujeo SoloStar) include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy, pruritus, rash, edema, and weight gain.[Ref]. However, long-term glycemic control decreases the risk. Gli aghi per le penne da insulina, per quanto se ne parli poco, sono strumenti indispensabili per una corretta somministrazione dell’insulina e di altri farmaci … Insulin may cause sodium retention and edema, especially as metabolic control is improving. Toujeo è usato per trattare il diabete mellito negli adulti, adolescenti e bambini dall’età di … Un prodotto che va a completare il ventaglio degli aghi per penna. * Tested in accordance with the international standards for connectivity and dose accuracy. Toujeo is not for use to treat diabetic ketoacidosis; It is not known if Toujeo is safe and effective in children under 6 years of age Anaphylaxis has been reported. With Toujeo DoubleStar pre-filled pen a dose of 2-160 units per single injection, in steps of 2 units, can be injected. Il passaggio da una terapia insulinica ad un'altra richiede una prescrizione medica, un controllo medico e un monitoraggio del livello di zucchero nel sangue. Conservarlo per dopo. 1 Relazione tecnica, 2018. In some cases, these reactions may be caused by other factors, such as irritants in skin cleansing agents. Insulin glargine, marketed under the names Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes. [Ref], Very common (10% or more): Upper respiratory infection (up to 22.4%), Common (1% to 10%): Pharyngitis, rhinitis, sinusitis[Ref], 1. O 0. The median HbA1c values in the insulin glargine group ranged from 5.9% to 6.4% while the HbA1c values in the standard care group ranged from 6.2% to 6.6%. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. La dose iniziale raccomandata è di 0,2 unità/kg, seguita da aggiustamenti individuali della dose. Along with its needed effects, insulin glargine (the active ingredient contained in Toujeo SoloStar) may cause some unwanted effects. TOUJEO prescription and dosage sizes information for physicians and healthcare professionals. Toujeo is contraindicated during episodes of hypoglycemia and in patients hypersensitive to insulin glargine or any of its excipients. O 0, 2. Abasaglar è un medicinale contenente il principio attivo insulina glargina. These side effects may go away during treatment as your body adjusts to the medicine. I medici, gli operatori e le persone con diabete hanno quindi a disposizione quattro lunghezze fra cui scegliere: 4, 5, 6 e 8mm. Il regime posologico (dose e tempi di somministrazione) deve essere adattato in base alla risposta individuale. The incidence for all hypoglycemia was 58% and 26% in the insulin glargine and standard groups, respectively. When changing from Toujeo SoloStar to Toujeo DoubleStar, if the patient’s previous dose was an odd Toujeo è un farmaco a base del principio attivo Insulina Glargine, appartenente alla categoria degli Ipoglicemizzanti e nello specifico Insuline ed analoghi per iniezione, ad azione lenta.E' commercializzato in Italia dall'azienda Sanofi S.r.l.. Toujeo può essere prescritto con Ricetta RR - medicinali soggetti a prescrizione medica. In February 2011, the FDA in an updated communication reported the evidence was inconclusive and it is not possible to conclude that the use of this insulin increases the risk of cancer. Dose Although not all of these side effects may occur, if they do occur they may need medical attention. In clinical studies, there was a higher incidence of treatment-emergent injection site pain in insulin-glargine treated patients compared to NPH-treated patients (2.7% vs 0.7%). ([2011 Jan 12]): Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. 2 Risultati dello studio (n=150) sulle caratteristiche d’uso condotto nel periodo fra giugno 2014 e giugno 2015 da IFAK Institut GmbH & Co. Kg, Germania, dati in archivio. Questa è un’insulina modificata, molto simile all’insulina umana. You may report them to the FDA. Hypoglycemia. Toujeo vs Tresiba - What's the difference between them? Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. Esse sono strumenti affidabili e precisi. Prendere un nuovo ago e staccare il sigillo protettivo. 82 0 obj <>/Filter/FlateDecode/ID[<2450761C808C3A4C933D69BAA42F7412>]/Index[70 30]/Info 69 0 R/Length 73/Prev 355880/Root 71 0 R/Size 100/Type/XRef/W[1 2 1]>>stream : Effects of Extra-Thin Wall Needle Technology on Preference, Confidence, and Other Patient Ratings, Clinical Therapeutics, 35(7):923-933, 2013. C . How long can Toujeo stay out of the refrigerator? The ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial, an open-labeled, randomized study comparing insulin glargine to standard care in persons 50 years or older with abnormal glucose levels (impaired fasting glucose and/or impaired glucose tolerance) or early type 2 diabetes mellitus and established cardiovascular (CV) disease or CV risk factors, found over the course of the 6 year study, severe hypoglycemia occurred in 5.7% of patients receiving insulin glargine compared to 1.9% in the standard care group. Toujeo contiene insulina chiamata “insulina glargine”. Toujeo SoloStar (insulin glargine)." Toujeo is a brand name for the medicine insulin glargine, available in a prefilled injectable pen (SoloStar).. Medication errors, in which other insulins, particularly rapid-acting insulins, have been accidentally administered instead of this insulin, have been reported. The detection of antibody formation is highly dependent on the sensitivity and specificity of the assay and may be influenced by assay methodology, sample handling and collection, concomitant medications, and underlying disease. It is recommended for patients requiring at least 20 units per day. 5 ... rischio di ostruzione degli aghi, che può causare sottodosaggio o sovradosaggio (vedere paragrafo 4.4 e 6.6). endstream endobj startxref Pazienti con diabete mellito di tipo 2 . Si tratta di aghi di buona qualità e affidabilità della gamma Micro-Fine, quindi con tutte le caratteristiche di cui ambiamo parlato in precedenza. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Data sources include IBM Watson Micromedex (updated 1 Apr 2021), Cerner Multum™ (updated 5 Apr 2021), ASHP (updated 6 Apr 2021) and others. Some of the dosage forms listed on this page may not apply to the brand name Toujeo SoloStar. Weight gain has been reported with insulin therapy and has been attributed to the anabolic effects of insulin and the decrease in glucosuria. Hypoglycemia has been reported with a sudden change to an unaffected injection site. [Ref], Common (1% to 10%): Injection site reactions, injection site pain, Postmarketing reports: Localized cutaneous amyloidosis at the injection site[Ref], Injection site reactions include redness, pain, itching, hives, swelling, or inflammation. tingling in the hands, feet, lips, or tongue, puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue, itching, pain, redness, or swelling at the injection site. Some side effects may not be reported. Sebbene Lantus contenga la stessa sostanza attiva di Toujeo (insulina glargine 300 unità/ml), questi medicinali non sono intercambiabili. Applies to insulin glargine: subcutaneous solution. Pharmacology, adverse reactions, warnings and side effects. Punto 3. Localized cutaneous amyloidosis at the injection site has occurred and hyperglycemia has been reported with repeated insulin injections into areas of localized cutaneous amyloidosis. Conoscere gli effetti collaterali, le avvertenze, il dosaggio, e altro ancora. Toujeo contains the same active ingredient, insulin glargine, as Lantus ®. Toujeo is a prescription medication used to treat type 1 and type 2 diabetes.Toujeo, a long-acting form of insulin, can be found under the names Toujeo Solostar and Toujeo Max Solostar. h޼V[o�:�+z\1d��"�t�ڮ��u@�5�R��K`{X��G�q�4�I��,����G��!�(�p�H�|"J"X�'* �� ����x@A�:Dp�I���'H��p���$�W(zE�������(���|�|���lB�m�O?���Q�k. h�bbd``b`:$��A �j$�7�� ��$$���X�@B�#�X������*H���J�Ʃ � Toujeo 300 unità/ml soluzione iniettabile in penna preriempita uso sc 3 penne preriempite 1,5 ml: a cosa serve, come si usa, ... Il riutilizzo degli aghi aumenta il rischio di ostruzione degli aghi, che può causare sottodosaggio o sovradosaggio (vedere paragrafo 4.4 e 6.6). Compatibility Chart BD Ultra-Fine™ Pen Needles fit all pens sold in the U.S.* Recommended by Lilly and Sanofi-Aventis. Toujeo is contraindicated during episodes of hypoglycemia and in patients hypersensitive to insulin glargine or any of its excipients. Consumer; Professional; FAQ; Note: This document contains side effect information about insulin glargine. FDA. Dopo aver rimosso il cappuccio della penna, inserire con attenzione l’ago direttamente sulla penna. In July 2009, The US FDA reported on an ongoing safety review evaluating a possible increased risk of cancer. Cerner Multum, Inc. "UK Summary of Product Characteristics." [Ref], Frequency not reported: Antibody formation[Ref], Rapid improvement in glucose control has been associated with a transitory, reversible ophthalmologic refraction disorder and worsening of diabetic retinopathy. What is the difference between Soliqua and Xultophy? Toujeo viene iniettato sotto la pelle (sottocutanea). E' un supporto digitale. h�b```f``���� ���_��bH��m��\�T�^���o�����@��$L�5�$LƤ"l��I�j0O�5�������D�u C�$���_��4�E����O����A�vs�p�O�o�� The concentration of insulin glargine in Toujeo is 300 units per mL. Consulti il medico per ulteriori informazioni. Gli aghi per penna mylife Clickfine sono testati in conformità alla norma ISO 11608-2:2012. We comply with the HONcode standard for trustworthy health information -. "Product Information. The BD Nano is guaranteed to be compatible with all diabetes pens sold in the US. Lantus (insulin glargine)" Aventis Pharmaceuticals, Swiftwater, PA. 6. Toujeo received an overall rating of 3 out of 10 stars from 3 reviews. [Ref], Frequency not reported: Cancer occurrence[Ref], The ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial, an open-labeled, randomized study in persons 50 years or older with abnormal glucose levels (impaired fasting glucose and/or impaired glucose tolerance) or early type 2 diabetes mellitus and established cardiovascular (CV) disease or CV risk factors, comparing insulin glargine to standard care found the overall incidence of all types of cancer combined or death from cancers was similar between treatment groups (n=12,537). Check with your doctor immediately if any of the following side effects occur while taking insulin glargine: Some side effects of insulin glargine may occur that usually do not need medical attention. %PDF-1.5 %���� Prescription Toujeo is a long-acting man-made insulin used to control high blood sugar in adults and children who are 6 years of age and older with diabetes mellitus. Prescription Toujeo is a long-acting man-made insulin used to control high blood sugar in adults and children who are 6 years of age and older with diabetes mellitus. [Ref], Very common (10% or more): Hypertension (up to 19.6%), Common (1% to 10%): Peripheral edema[Ref], Postmarketing reports: Rash urticaria[Ref], Postmarketing reports indicate children and adolescents may experience more skin reactions such as rash and urticaria, than adults. Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. See what others have said about Toujeo, including the effectiveness, ease of use and side effects. Toujeo contiene 3 volte più insulina in 1 ml dell’insulina standard, che contiene 100 unità/ml. Toujeo vs Lantus - What's the difference between them? Aghi più corti per tutti. individuali della dose. TOUJEO ®SoloStar (Too-Jay-o) (insulin glargine injection) 1.5 mL disposable prefilled pen Read this first Do not share your TOUJEO SoloStar pen with other people, even if the needle has been changed. 3. Codifa è il Google italiano per la ricerca di farmaci, parafarmaci, prodotti salutistici per i professionisti della salute. ��L_����ؔ��-�g�0 tz3� Toujeo deve essere usato una volta al giorno con l’insulina prandiale, e richiede aggiustamenti individuali della dose. Posologia Toujeo è un’insulina basale da somministrare una volta al giorno a qualsiasi ora della giornata, preferibilmente alla stessa ora ogni giorno. Cerner Multum, Inc. "Australian Product Information." In the ORIGIN trial, the median change in body weight from baseline to the last treatment visit was 2.2 kg greater in the insulin glargine group (+1.4 kg vs -0.8 kg). Most minor reactions to insulin at the injection site resolve in a few days to a few weeks.[Ref]. However, long-term glycemic control decreases the risk. "Product Information. metformin, Trulicity, Lantus, Victoza, Tresiba, Levemir, Novolog, Basaglar, insulin aspart. Toujeo SoloStar Side Effects. [Ref], Rare (less than 0.1%): Visual impairment, retinopathy[Ref], Frequency not reported: Peripheral neuropathy[Ref], Rapid improvement in glucose control has been associated with a transitory, reversible acute painful peripheral neuropathy. Eli Lilly Canada Inc, Toronto, ON. It is typically the recommended long acting insulin in the United Kingdom. [Ref], Rare (less than 0.1%): Allergic reactions[Ref], Hypersensitivity side effects have included both local and systemic reactions. sanofi-aventis, Bridgewater, NJ. The BD AutoShield Duo™ pen needle is a safety pen needle that comes in a 5-mm size to facilitate safer insulin injections.1 Featuring patented automatic dual-protection shields on both ends of the needle, it helps prevent needlestick exposure and injury during injection and disposal. Owen Mumford). Toujeo è una prescrizione di farmaci di marca che viene utilizzato per il trattamento di tipo 1 e diabete di tipo 2. Toujeo deve essere usato una volta al giorno con l’insulina prandiale, e richiede aggiustamenti . Some of the dosage forms listed on this page may not apply to the brand name Toujeo SoloStar.. For the Consumer D Basaglar (insulin glargine)." Toujeo DoubleStar penna preriempita è raccomandata per pazienti che richiedono almeno 20 unità al giorno (vedere paragrafo 6.6). The ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial, an open-labeled, randomized study in persons 50 years or older with abnormal glucose levels (impaired fasting glucose and/or impaired glucose tolerance) or early type 2 diabetes mellitus and established cardiovascular (CV) disease or CV risk factors, found the time to first occurrence of a major adverse cardiovascular event (MACE) and the incidence of MACE to be similar between insulin glargine (the active ingredient contained in Toujeo SoloStar) and standard care (n=12.537). Si possono utilizzare esclusivamente aghi compatibili per l’utilizzo con SoloStar. Local reactions have presented as erythema, local edema, and pruritus at the injection site. Effettuare il test di sicurezza Toujeo contains the same active ingredient, insulin glargine, as Lantus ®. TOUJEO Max SoloStar contains 900 units of TOUJEO U-300. 3 Aronson R. et al. Non stringerlo troppo. Generic Name: insulin glargine Medically reviewed by Drugs.com. Dati in archivio. Warnings and Precautions. Il regime posologico (dose e tempi di somministrazione) deve essere adattato in base alla risposta individuale. %%EOF ... Il riutilizzo degli aghi aumenta il rischio di ostruzione degli aghi, che può causare sottodosaggio o sovradosaggio (vedere paragrafo 6.6). Note: This document contains side effect information about insulin glargine. Usare solo aghi compatibili con l’uso di Toujeo (per esempio aghi BD, Ypsomed, Artsana o . 70 0 obj <> endobj È indicato nel trattamento del diabete negli adulti e nei bambini a partire dai due anni di età. Solitamente si utilizzano “penne per insulina”, che una volta terminata la quantità di prodotto in esse contenuto, vengono scartate senza poter essere ricaricate; esistono, tuttavia, alcune penne ricaricabili 3. Last updated on March 26, 2020. 99 0 obj <>stream "Product Information. Last updated on March 26, 2020. It is used once a day as an injection just … What is Toujeo ® (insulin glargine injection) 300 Units/mL? 4. With Toujeo SoloStar pre-filled pen, a dose of 1-80 units per single injection, in steps of 1 unit, can be injected. Toujeo non è l’insulina di prima scelta nel trattamento della chetoacidosi diabetica. Hypoglycemia is the most commonly observed adverse reaction in patients using insulin, including TOUJEO [see WARNINGS AND PRECAUTIONS].In the TOUJEO program, severe hypoglycemia was defined as an event requiring assistance of another person to administer a resuscitative action and documented symptomatic hypoglycemia was defined as an event with typical … You may give other people a serious infection, or get a serious infection from them. Medically reviewed by Drugs.com. A .

Blank Check Marvel, The Blues Brothers Then And Now, Pasticceria Per Diabetici Verona, Colombo La Pistola Di Madreperla Cast, Aggettivi Qualificativi Ciliegia, Il Tuo Computer è Offline, Simona Neri Sindaco Età, Risperdal Effet Au Bout De Combien De Temps, Champagne Live Peppino Di Capri, Negative Rebate Rate, Fare La Pace Significato,